Level Four Advisory Services, LLC Axonics, Inc. Transaction History

Level Four Advisory Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$56.67 - $69.36 $8,727 - $10,681	154 Added 2.8%	5,661 $390,000
Q4 2023 Feb 08, 2024	SELL	$49.38 - $63.75 $58,268 - $75,225	-1,180 Reduced 17.65%	5,507 $342,000
Q3 2023 Nov 13, 2023	BUY	$48.64 - $62.51 $325,255 - $418,004	6,687 New	6,687 $375,000
Q4 2022 Feb 13, 2023	BUY	$59.56 - $76.6 $488,392 - $628,120	8,200 New	8,200 $512,000
Q4 2021 Feb 11, 2022	SELL	$50.01 - $73.35 $226,995 - $332,935	-4,539 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$59.21 - $78.66 $268,754 - $357,037	4,539 New	4,539 $295,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Level Four Advisory Services, LLC with notifications on news.